Preclinical antihypertensive efficacy and immunogenicity in humans of a vaccine against angiotensin II based on virus-like particles (VLPs) by Tissot, A, Ambuhl, P, Fulurija, A, Maurer, P, Jennings, G, Nussberger, J, Sabat, R, Volk, H, Wagner, F, Nief, V, Schellekens, C, Sladko, K, Pfister, T, Rettenbacher, M, Muller, P, Bachmann, M

A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity. by Ambühl, P, Tissot, A, Fulurija, A, Maurer, P, Nussberger, J, Sabat, R, Nief, V, Schellekens, C, Sladko, K, Roubicek, K, Pfister, T, Rettenbacher, M, Volk, H, Wagner, F, Müller, P, Jennings, G, Bachmann, M